225 related articles for article (PubMed ID: 22952554)
21. Hepatitis C virus infection in patients with B-cell non-Hodgkin's lymphoma.
Mizorogi F; Hiramoto J; Nozato A; Takekuma Y; Nagayama K; Tanaka T; Takagi K
Intern Med; 2000 Feb; 39(2):112-7. PubMed ID: 10732826
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis C virus infection, mixed cryoglobulinemia, and non-Hodgkin's lymphoma: an emerging picture.
Dammacco F; Gatti P; Sansonno D
Leuk Lymphoma; 1998 Nov; 31(5-6):463-76. PubMed ID: 9922037
[TBL] [Abstract][Full Text] [Related]
23. Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on Toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates.
Li K; Li NL; Wei D; Pfeffer SR; Fan M; Pfeffer LM
Hepatology; 2012 Mar; 55(3):666-75. PubMed ID: 22030901
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C Virus-Associated B-Cell Non-Hodgkin's Lymphoma: Clinical and Therapeutic Challenges.
Russi S; Sansonno L; Sansonno D
Curr Drug Targets; 2017; 18(7):766-771. PubMed ID: 26844565
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C virus - associated B cell non-Hodgkin's lymphoma.
Mihăilă RG
World J Gastroenterol; 2016 Jul; 22(27):6214-23. PubMed ID: 27468211
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis C virus (HCV) and lymphomagenesis.
Weng WK; Levy S
Leuk Lymphoma; 2003 Jul; 44(7):1113-20. PubMed ID: 12916862
[TBL] [Abstract][Full Text] [Related]
27. B cell non-Hodgkin's lymphoma in chronic hepatitis C virus patients: An interesting relationship.
Hamdy HS; Abdelkader NA; Mansour A; Allam EH; El-Wakiel HM; Elshenawy D
Indian J Gastroenterol; 2015 Mar; 34(2):127-34. PubMed ID: 25917521
[TBL] [Abstract][Full Text] [Related]
28. Constitutive NF-kappaB and NFAT activation leads to stimulation of the BLyS survival pathway in aggressive B-cell lymphomas.
Fu L; Lin-Lee YC; Pham LV; Tamayo A; Yoshimura L; Ford RJ
Blood; 2006 Jun; 107(11):4540-8. PubMed ID: 16497967
[TBL] [Abstract][Full Text] [Related]
29. Abnormal B-cell activation associated with TALL-1 over-expression and SOCS-1 suppression during chronic hepatitis C virus infection.
Moorman J; Dong ZP; Ni L; Zhang C; Borthwick T; Yao ZQ
Immunology; 2009 Oct; 128(2):227-35. PubMed ID: 19740379
[TBL] [Abstract][Full Text] [Related]
30. In Situ Hepatitis C NS3 Protein Detection Is Associated with High Grade Features in Hepatitis C-Associated B-Cell Non-Hodgkin Lymphomas.
Canioni D; Michot JM; Rabiega P; Molina TJ; Charlotte F; Lazure T; Davi F; Settegrana C; Berger F; Alric L; Cacoub P; Terrier B; Suarez F; Sibon D; Dupuis J; Feray C; Tilly H; Pol S; Deau Fischer B; Roulland S; Thieblemont C; Leblond V; Carrat F; Hermine O; Besson C;
PLoS One; 2016; 11(6):e0156384. PubMed ID: 27257992
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia.
Luppi M; Grazia Ferrari M; Bonaccorsi G; Longo G; Narni F; Barozzi P; Marasca R; Mussini C; Torelli G
Leukemia; 1996 Feb; 10(2):351-5. PubMed ID: 8637247
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C infection and lymphoproliferative disease: accidental comorbidities?
Khoury T; Chen S; Adar T; Jacob EO; Mizrahi M
World J Gastroenterol; 2014 Nov; 20(43):16197-202. PubMed ID: 25473174
[TBL] [Abstract][Full Text] [Related]
33. Heterogeneity and coexistence of oncogenic mechanisms involved in HCV-associated B-cell lymphomas.
Carloni G; Fioretti D; Rinaldi M; Ponzetto A
Crit Rev Oncol Hematol; 2019 Jun; 138():156-171. PubMed ID: 31092372
[TBL] [Abstract][Full Text] [Related]
34. Multifaceted functions of B cells in chronic hepatitis C virus infection.
Mondelli MU
Antiviral Res; 2003 Oct; 60(2):111-5. PubMed ID: 14638406
[TBL] [Abstract][Full Text] [Related]
35. Differential regulation of T and B lymphocytes by PD-1 and SOCS-1 signaling in hepatitis C virus-associated non-Hodgkin's lymphoma.
Yao ZQ; Ni L; Zhang Y; Ma CJ; Zhang CL; Dong ZP; Frazier AD; Wu XY; Thayer P; Borthwick T; Chen XY; Moorman JP
Immunol Invest; 2011; 40(3):243-64. PubMed ID: 21291295
[TBL] [Abstract][Full Text] [Related]
36. Serum biomarker signature identifies patients with B-cell non-Hodgkin lymphoma associated with cryoglobulinemia vasculitis in chronic HCV infection.
Terrier B; Chaara W; Dufat L; Geri G; Rosenzwajg M; Musset L; Sène D; Saadoun D; Six A; Klatzmann D; Cacoub P
Autoimmun Rev; 2014 Mar; 13(3):319-26. PubMed ID: 24220267
[TBL] [Abstract][Full Text] [Related]
37. The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis.
Quinn ER; Chan CH; Hadlock KG; Foung SK; Flint M; Levy S
Blood; 2001 Dec; 98(13):3745-9. PubMed ID: 11739181
[TBL] [Abstract][Full Text] [Related]
38. Transfusion-associated TT virus co-infection in patients with hepatitis C virus is associated with type II mixed cryoglobulinemia but not with B-cell non-Hodgkin lymphoma.
Cacoub P; Rosenthal E; Gerolami V; Hausfater P; Ghillani P; Sterkers Y; Thibault V; Khiri H; Piette JC; Halfon P
Clin Microbiol Infect; 2003 Jan; 9(1):39-44. PubMed ID: 12691541
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
[TBL] [Abstract][Full Text] [Related]
40. The pathophysiology of HCV induced B-cell clonal disorders.
Landau DA; Saadoun D; Calabrese LH; Cacoub P
Autoimmun Rev; 2007 Sep; 6(8):581-7. PubMed ID: 17854753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
